Haemonetics (HAE) Tops Q2 EPS by 2c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.07 --0%
Revenue Growth %: +2.3%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +2.3%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $242 million versus the consensus estimate of $233.45 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James cuts Delta and JetBlue ratings ahead of Q2 earnings
- Canaccord Reiterates Buy Rating on Seer Inc. (SEER)
- IP Strategy reports June validator results with 200,651 $DATA tokens earned
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
